JournalArta
Thursday, November 19, 2026 · JakartaS&P 7,245.47 ▼1.07%USD/IDR 18,280 ▲0.29%
JournalArta
Global Edition
beyond headlines
Advertisement

Alzheimer’s Can Stay Hidden as the Brain Copes With Damage

Some people show no signs of dementia despite having Alzheimer’s-related changes in their brains. Researchers call this resilience, but it can also delay diagnosis. Blood-based disease markers, combined with cognitive tests, could help researchers understand how well a person is coping with the disease.

By matthew jonathan
November 19, 20262 min read
Alzheimer’s Can Stay Hidden as the Brain Copes With Damage
Alzheimer’s Can Stay Hidden as the Brain Copes With Damage

Neuroscientists studying Alzheimer’s have found that the brain can hide signs of the disease, even as brain cells are damaged or lost. That resilience may delay diagnosis and leave patients with less time to benefit from treatment.

Examinations after death have found Alzheimer’s indicators in the brains of around a third of older people who showed no signs of dementia during life. Researchers call their ability to cope with the disease resilience.

Resilience is not the same as resistance. Some people accumulate little of the proteins associated with Alzheimer’s despite having a high genetic risk; researchers call that resistance.

Advertisement

Resilient people, by contrast, can build up those proteins while continuing to function. Some lose relatively few brain cells. Others lose cells but still think clearly, or experience decline so slowly that symptoms are less noticeable.

Memory tests can miss changes

Alzheimer’s develops in stages. Proteins called amyloid and tau first build up as plaques and clumps known as tangles. Brain cells are then damaged and die, before memory and thinking begin to fail.

Women may be more likely to have brain changes that are masked by performance on memory tests. On average, women have better verbal memory than men throughout life, including recall of words, names and stories.

Advertisement

Tests used to diagnose Alzheimer’s rely heavily on verbal memory. Research has found that women with signs of the disease scored better on memory tests than men with similar signs.

A similar pattern appears in people with high cognitive reserve. That term describes the brain’s ability to adapt when it faces a setback, including damage associated with disease or aging.

Education and mentally demanding work can build cognitive reserve over a lifetime. People with high reserve tend to develop symptoms later, but their brain function tends to decline faster once symptoms appear. By then, the disease is usually advanced.

Delayed diagnosis can limit treatment

A delayed diagnosis can postpone support. It may also mean missing the period when treatment could help most.

Advertisement

Drugs currently approved to slow Alzheimer’s progression must be taken in the early stages to potentially have an effect.

Resilience also complicates drug trials. People who cope well may decline slowly whether they receive a treatment or a placebo, potentially making a drug appear weaker or stronger than it is.

One Alzheimer’s drug was found to be more effective in less resilient people. There was no clear benefit for highly resilient people, even though they had high tau levels and similar cognitive function to the less resilient group.

Biomarkers are measurable signs of disease and can detect Alzheimer’s from a blood sample. Paired with cognitive tests, they could help researchers assess disease burden, damage and how well a person’s thinking has held up.

Advertisement
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1Brent Crude Slides 4.05% as Rising US Stockpiles Weigh on Oil
  2. 2UnitedHealth Shares Fall 10.2% Amid Medicare Audit Proposal
  3. 3PNB Shares Rally 5% as Bank Repeats Loan Growth Target
  4. 4Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
  5. 5Lainey Wilson and Devlin Hodges Married in Tennessee Cave
Advertisement
Don't Miss

Latest News

All stories →
  1. Markets · StocksEvolution Mining Share Price Tumbles 7.33%: Trading Volume 1.7x NormalNov 19
  2. WorldUN Court Finds Myanmar Committed Rohingya GenocideNov 19
  3. Business · Macro & PolicyChina Drug Deals Raise Supply Concerns, US Panel WarnsNov 19
  4. Markets · StocksSouth32 Share Price on Thursday: Tumbles 5.87%, Near a 3-Month LowNov 19
  5. Advertisement
  6. Markets · StocksInsurance Australia Share Price Latest: Little Changed on Thursday, Up 1.3% in a MonthNov 19
  7. World · United StatesWhite House Takes Pool Phones Before Trump Leaves ChinaNov 19
  8. Markets · StocksCommBank Share Price on Thursday: Rises 0.44%, Up 9.2% in a MonthNov 19
  9. Sport · More SportsCody Walker Lands Safely at Carlton After No. 3 BidNov 19